tradingkey.logo

Co-Diagnostics Inc

CODX
查看详细走势图
0.235USD
-0.006-2.41%
收盘 12/26, 16:00美东报价延迟15分钟
11.31M总市值
亏损市盈率 TTM

Co-Diagnostics Inc

0.235
-0.006-2.41%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-2.41%

5天

-10.95%

1月

-37.05%

6月

-11.95%

今年开始到现在

-68.67%

1年

-69.01%

查看详细走势图

TradingKey Co-Diagnostics Inc股票评分

单位: USD 更新时间: 2025-12-26

操作建议

Co-Diagnostics Inc当前公司基本面数据相对非常健康,增长潜力稳定。当前估值合理,在医疗设备与耗材行业排名128/207位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价1.25。中期看,股价处于下降通道。近一个月,市场表现非常差,但技术面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Co-Diagnostics Inc评分

相关信息

行业排名
128 / 207
全市场排名
327 / 4563
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 2 位分析师
买入
评级
1.250
目标均价
+260.33%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Co-Diagnostics Inc亮点

亮点风险
Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
业绩增长期
公司处于发展阶段,最新年度总收入3.92M美元
利润高增长
公司净利润处于行业前列,最新年度总收入3.92M美元
估值高估
公司最新PE估值-0.24,处于3年历史高位
机构减仓
最新机构持股11.14M股,环比减少2.69%
詹姆斯·西蒙斯持仓
明星投资者詹姆斯·西蒙斯持仓,最新持仓市值867.52K
活跃度增加
近期活跃度增加,过去20天平均换手率10.46

Co-Diagnostics Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Co-Diagnostics Inc简介

Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
公司代码CODX
公司Co-Diagnostics Inc
CEOEgan (Dwight H)
网址https://codiagnostics.com/

常见问题

Co-Diagnostics Inc(CODX)的当前股价是多少?

Co-Diagnostics Inc(CODX)的当前股价是 0.235。

Co-Diagnostics Inc的股票代码是什么?

Co-Diagnostics Inc的股票代码是CODX。

Co-Diagnostics Inc股票的52周最高点是多少?

Co-Diagnostics Inc股票的52周最高点是1.550。

Co-Diagnostics Inc股票的52周最低点是多少?

Co-Diagnostics Inc股票的52周最低点是0.228。

Co-Diagnostics Inc的市值是多少?

Co-Diagnostics Inc的市值是11.31M。

Co-Diagnostics Inc的净利润是多少?

Co-Diagnostics Inc的净利润为-37.64M。

现在Co-Diagnostics Inc(CODX)的股票是买入、持有还是卖出?

根据分析师评级,Co-Diagnostics Inc(CODX)的总体评级为买入,目标价格为1.250。

Co-Diagnostics Inc(CODX)股票的每股收益(EPS TTM)是多少

Co-Diagnostics Inc(CODX)股票的每股收益(EPS TTM)是-0.974。
KeyAI